| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PHAR.1649 |
| P698 | PubMed publication ID | 26598097 |
| P50 | author | Christopher M Bland | Q56223860 |
| P2093 | author name string | Milena McLaughlin | |
| P Brandon Bookstaver | |||
| Lea S Eiland | |||
| Kayla R Stover | |||
| Brooke Griffin | |||
| P2860 | cites work | Fetal safety of erythromycin. An update of Swedish data | Q30718671 |
| Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations | Q33608040 | ||
| Drug treatment for tuberculosis during pregnancy: safety considerations | Q33953505 | ||
| Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection | Q34087935 | ||
| Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study | Q34199799 | ||
| Physiologic changes in pregnancy and their effect on drug disposition | Q34308678 | ||
| Effects of antibacterials on the unborn child: what is known and how should this influence prescribing | Q34458621 | ||
| Tuberculosis care for pregnant women: a systematic review. | Q34560317 | ||
| Relationship between prenatal antibiotic use and asthma in at-risk children | Q35155854 | ||
| Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity | Q35328729 | ||
| Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol | Q35625262 | ||
| Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection | Q36071501 | ||
| Investigation of metronidazole use during pregnancy and adverse birth outcomes | Q36172432 | ||
| Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach | Q36263475 | ||
| Safety of macrolides during pregnancy | Q36636707 | ||
| Trimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study | Q36651303 | ||
| Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight | Q36673153 | ||
| Fetal safety of macrolides | Q36969814 | ||
| Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring | Q36994734 | ||
| Once-daily dosing of gentamicin in obstetrics and gynecology | Q37115625 | ||
| Effect of polymyxin B on gram-negative bacterial infection during pregnancy | Q37611074 | ||
| Erythromycin, clarithromycin, and azithromycin: are the differences real? | Q37885856 | ||
| Evolving knowledge of the teratogenicity of medications in human pregnancy. | Q37902132 | ||
| Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study | Q37962481 | ||
| Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria | Q38160759 | ||
| Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity | Q38246106 | ||
| The safety of quinolones in pregnancy | Q38269527 | ||
| Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis | Q38376473 | ||
| Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis | Q40364770 | ||
| Placental transfer of drugs administered to the mother | Q40530290 | ||
| Antiinfective therapy for pregnant or lactating patients in the emergency department | Q41537963 | ||
| Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? | Q42199600 | ||
| Use of antibiotics during pregnancy increases the risk of asthma in early childhood | Q42287087 | ||
| Critical pneumonia complicating early-stage pregnancy | Q43149062 | ||
| A prospective controlled multicentre study of clarithromycin in pregnancy | Q43503255 | ||
| Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study | Q43516283 | ||
| Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy | Q46694681 | ||
| Teratogenic potential of vaginal metronidazole treatment during pregnancy | Q46826946 | ||
| Antibiotics in Pregnancy A Prospective Cohort Study on the Policy of Antibiotic Prescription | Q58278414 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1052-1062 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | A Review of Antibiotic Use in Pregnancy | |
| P478 | volume | 35 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q42670065 | Antibiotic use during pregnancy: how bad is it? |
| Q49631079 | Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period |
| Q94563595 | Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty |
| Q48017848 | Doxycycline in the management of sexually transmitted infections |
| Q59793580 | Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: Consideration of toxicological perspectives |
| Q92306472 | Effect of In-Utero Antibiotic Exposure on Childhood Outcomes: Methods and Baseline Data of the Fetal Antibiotic EXposure (FAX) Cohort Study |
| Q90028070 | Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis |
| Q92740716 | Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis |
| Q38725331 | Emergency Department Urinary Antibiograms Differ by Specific Patient Group |
| Q92493935 | Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary |
| Q98726083 | Epidemiology, definition and treatment of complicated urinary tract infections |
| Q47550799 | Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father |
| Q98386276 | Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study |
| Q90040795 | Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot |
| Q89712269 | Safety of MenACWY-CRM vaccine exposure during pregnancy |
| Q60308377 | The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts |
| Q40068337 | Vigilance on use of drugs, herbal products and food supplements during pregnancy: focus on fosfomycin |
| Q88437523 | [Drug therapy of otorhinolaryngological diseases in pregnancy : An update] |
Search more.